Breaking News

You are here » Indian-Commodity  :  Commodities  :  Crude Oil  :  Mentha oil futures edge marginally higher on rising demand

12-Aug2016

Mentha oil futures edge marginally higher on rising demand

Mentha oil futures edged marginally higher on MCX as participants were building fresh positions, driven by rising demand from consuming industries at the spot market. Besides, tight stocks position following restricted arrivals from major producing belts of Chandausi in Uttar Pradesh also added support to mentha oil prices uptrend.

The contract for August delivery was trading at Rs 911.20, up by 0.63% or Rs 5.70 from its previous closing of Rs 905.50.The open interest of the contract stood at 5709 lots.

The contract for September delivery was trading at Rs 923.00, up by 0.65% or Rs 6.00 from its previous closing of Rs 917.00. The open interest of the contract stood at 2033 lots on MCX.


Related News

View all news

Crude oil futures end higher on Friday

Crude oil futures ended higher on Friday on worries about possible impact of US sanctions on Iran's oil exports on crude supply in the market coupled with potential US-Saudi tensions. Prices also supported......

Crude oil futures extend losses on Thursday

Extending previous session losses, crude oil futures ended lower on Thursday due to a sharp jump in US crude inventories last week and on demand growth concerns. The Energy Information Administration's......

Crude oil futures trade lower on MCX

Crude oil futures traded lower on MCX, as speculators reduced their bets due to trade war concerns combined with surging US oil stockpiles reported on Thursday. Though, signs of surging demand in China,......

Top News

View all news

Bhansali Engineering Polymers reports 33% fall in Q2 net profit

Bhansali Engineering Polymers has reported results for second quarter ended September 30, 2018.The company has reported 32.71% fall in its net profit at Rs 16.89 crore for the quarter under review as compared......

Biocon, Mylan N.V. receive positive CHMP opinion for Ogivri

Biocon and Mylan N.V. have announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Ogivri, a biosimilar......

Lupin Neurosciences receives positive CHMP opinion for NaMuscla

Lupin Neurosciences, a specialty pharma division of Lupin has announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA),......